Logo Assembly Logo Hemicycle

For a ban on conversion practices

Amendment No. 8 | Doc. 16315 | 28 January 2026

Signatories:
Mr Paweł JABŁOŃSKI, Poland, ECPA ; Mr Pekka AITTAKUMPU, Finland, ECPA ; Ms Iwona ARENT, Poland, ECPA ; Mr Bob De BRABANDERE, Belgium, ECPA ; Mr Vladimir ĐORĐEVIĆ, Serbia, ECPA ; Mr Jan KANTHAK, Poland, ECPA ; Ms Martina KEMPF, Germany, ECPA ; Mr Daniel MILEWSKI, Poland, ECPA ; Ms Victoria TIBLOM, Sweden, ECPA ; Mr Markus WIECHEL, Sweden, ECPA
Origin
2026 - First part-session
In the draft resolution, after paragraph 8.1.1, insert the following paragraph:

"introduce legislation prohibiting the prescription or administration of puberty‑suppressing hormones (puberty blockers) to persons under 18 years of age outside strictly defined, exceptional clinical emergency contexts and always with paternal consent; and require clear, evidence‑based national clinical guidance and oversight and establish sanctions for the unlawful provision thereof;"

Explanatory note

Self explanatory. Life-changing drugs should never be administered to minors incapable of understanding consequences lasting their entire lives. Parental consent should always be required.